drugset / Trial / NCT04524026
RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of the randomised controlled study (RCT) is to identify novel strategies that can improve the luteal phase endocrinology after ovarian stimulation, with the aim of using less or no luteal support in IVF while making the endometrium thinner and more receptive to embryo implantation.
Timeline
- Start
- 2018-09-18
- Primary completion
- 2020-11-30
- Completion
- 2020-11-30
Outcome
Met primary endpoint
paper 8.0 (6.8-11.5) days compared with 5.0 (5.0-6.8) days in the intervention and control group, respectively (P < 0.001). PMID 35779242 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 5 mg | — |
Indications
No indication recorded.